"Antonius. Zorg die meebeweegt. Welkom bij Antonius. De naam waaronder Thuiszorg Zuidwest Friesland en Antonius Ziekenhuis samen verder gaan. Wij leveren zorg in Friesland, de Noordoostpolder en op Urk. Dit doen we bij u thuis als het kan en in het ziekenhuis als het moet."

During the past decade, Antonius Ziekenhuis conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 8 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Antonius Ziekenhuis" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Dutch Colorectal Cancer Group" with 3 trials sponsored, "Maastricht University Medical Center" with 3 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored and "University Medical Center Groningen" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Antonius Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 3 trials as a collaborator, "Borstkanker Onderzoek Groep" with 2 trials as a collaborator, "Dutch Cancer Society" with 2 trials as a collaborator, "Fonds NutsOhra" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Antonius Ziekenhuis" are "Prostate Cancer" (4 trials), "Atrial Fibrillation" (3 trials), "Breast Neoplasms" (2 trials), "Colon Cancer" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Antonius Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Antonius Ziekenhuis" are "Drug" (26 trials), "Other" (6 trials), "Procedure" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Digoxin" (2 trials), "Enzalutamide" (2 trials), "Ibrutinib" (2 trials) and "Ixekizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Antonius Ziekenhuis" are 27 trials for "All" genders, 6 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Antonius Ziekenhuis". undefined are not yet recruiting, 7 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Antonius Ziekenhuis, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Antonius Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".

Antonius Ziekenhuis has several departments that took part in Clinical trials: "Antonius Ziekenhuis Sneek; Department of Rheumatology" - 2 trials